Skip to main content
    I

    ICON PLC (ICLR)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $175.13
    +6.16 (+3.65%)

    Market Cap: $13.04B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    95%(37/39)
    Avg Surprise
    +0.97%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$2.65
    Range$2.56 - $2.70
    15 analysts
    EPS RevisionsNo revisions (7d)
    0
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$2.68-1.3%
    60d ago$2.67-1.0%
    30d ago$2.67-0.8%
    7d ago$2.65-0.2%
    Current$2.65
    Revenue Consensus
    $2.0B
    Range$2.0B - $2.0B
    14 analysts
    Period ending Dec 31, 2026
    EPS Consensus$2.99
    Range$2.82 - $3.27
    18 analysts
    Revenue Consensus
    $2.1B
    Range$2.0B - $2.3B
    17 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$2.99---
    Sep 26EST
    		-$2.65---
    Jun 26
    Reported Jul 29
    		$2.35$2.26+3.98%Beat-27.9%
    Mar 26
    Reported May 27
    		$2.22$2.16+2.78%Beat-30.4%
    Dec 25
    Reported Feb 25
    		$2.52$3.31-23.87%Miss-26.5%
    Sep 25
    Reported Oct 22
    		$3.31$3.28+0.91%Beat-1.2%
    Jun 25
    Reported Jul 23
    		$3.26$3.18+2.52%Beat-13.1%
    Mar 25
    Reported Apr 30
    		$3.19$3.09+3.24%Beat-8.1%
    Dec 24
    Reported Feb 19
    		$3.43$3.43+0.14%Beat-0.9%
    Sep 24
    Reported Oct 23
    		$3.35$3.84-12.76%Miss+1.5%
    Jun 24
    Reported Jul 24
    		$3.75$3.67+2.18%Beat+20.6%
    Mar 24
    Reported Apr 24
    		$3.47$3.41+1.76%Beat+19.7%
    Dec 23
    Reported Feb 21
    		$3.46$3.44+0.58%Beat+10.5%
    Sep 23
    Reported Oct 25
    		$3.30$3.28+0.61%Beat+10.0%
    Jun 23
    Reported Jul 26
    		$3.11$3.08+0.97%Beat+8.7%
    Mar 23
    Reported Apr 26
    		$2.90$2.87+1.05%Beat+5.1%
    Dec 22
    Reported Feb 22
    		$3.13$3.05+2.62%Beat+19.0%
    Sep 22
    Reported Nov 2
    		$3.00$2.94+2.04%Beat+17.6%
    Jun 22
    Reported Jul 27
    		$2.86$2.79+2.51%Beat+34.9%
    Mar 22
    Reported Apr 27
    		$2.76$2.69+2.60%Beat+34.0%
    Dec 21
    Reported Feb 22
    		$2.63$2.62+0.38%Beat+38.4%
    Sep 21
    Reported Nov 3
    		$2.55$2.46+3.66%Beat+48.3%
    Jun 21
    Reported Jul 21
    		$2.12$2.11+0.47%Beat+76.7%
    Mar 21
    Reported Apr 28
    		$2.06$1.97+4.57%Beat+21.2%
    Dec 20
    Reported Feb 24
    		$1.90$1.83+3.83%Beat+3.8%
    Sep 20
    Reported Oct 21
    		$1.72$1.54+11.69%Beat-1.1%
    Jun 20
    Reported Jul 22
    		$1.20$1.10+9.09%Beat-29.0%
    Mar 20
    Reported Apr 22
    		$1.70$1.70+0.00%Beat+4.3%
    Dec 19
    Reported Feb 19
    		$1.83$1.83+0.00%Beat+13.0%
    Sep 19
    Reported Oct 23
    		$1.74$1.74+0.00%Beat+13.0%
    Jun 19
    Reported Jul 24
    		$1.69$1.68+0.60%Beat+11.9%
    Mar 19
    Reported May 1
    		$1.63$1.60+1.88%Beat+14.8%
    Dec 18
    Reported Feb 20
    		$1.62$1.60+1.25%Beat+13.3%
    Sep 18
    Reported Oct 24
    		$1.54$1.54+0.00%Beat+14.1%
    Jun 18
    Reported Jul 25
    		$1.51$1.48+2.03%Beat+15.3%
    Mar 18
    Reported May 2
    		$1.42$1.42+0.00%Beat+10.1%
    Dec 17
    Reported Feb 15
    		$1.43$1.42+0.70%Beat+13.5%
    Sep 17
    Reported Oct 26
    		$1.35$1.32+2.27%Beat-
    Jun 17
    Reported Jul 27
    		$1.31$1.30+0.77%Beat-
    Mar 17
    Reported Apr 27
    		$1.29$1.28+0.78%Beat-
    Dec 16
    Reported Feb 16
    		$1.26$1.26+0.00%Beat-

    Key Metrics

    Valuation
    P/E Ratio16.84EV/EBITDA20.84x
    Price/FCF15.08xFCF Yield6.63%
    Profitability
    Profit Margin0.33%Operating Margin9.41%
    ROE0.29%ROIC1.98%
    Financial Health
    Debt/Equity0.36xInterest Coverage2.08x
    Current Ratio0.95xQuick Ratio0.95x
    Trading Statistics
    Beta1.24Avg Volume972.11K
    52-Week High$203.9152-Week Low$66.57

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$165.77
    SMA 20$167.32
    SMA 50$167.21
    SMA 200$145.79
    EMA 10$167.52
    EMA 20$167.19
    EMA 50$165.79
    EMA 200$154.89

    MACD

    Line: 0.23Signal: -0.30Hist: 0.53

    ADX

    ADX: 14.4+DI: 30.2-DI: 16.5

    Aroon & PSAR

    Aroon Up72.0
    Aroon DownN/A
    PSAR$157.38

    Bollinger Bands

    Upper Band$176.26
    Lower Band$158.38
    %B Position1069%(Upper)
    Band Width0.94

    RSI (14-Day)

    Neutral
    59.5

    Momentum Oscillators

    Stoch %K59.6
    Stoch %D45.3
    Williams %R-12.5
    ROC (10d)8.2%
    Momentum13.28
    CCI (20d)132.2
    MFI (14d)58.4

    Volatility Measures

    ATR (14d)$7.26(4.1%)
    StdDev (20d)4.47
    Hist Vol45.2%(High)

    Volume Flow

    VWAP$173.09
    OBV13.4M
    AD Line38.0M
    CMF (20d)0.051

    Volume Metrics

    Avg Vol (20d)969.8K
    Vol Ratio0.8x
    VWMA (20d)$167.86

    Pivot Points

    R3$178.99
    R2$174.66
    R1$171.81
    Pivot Point$167.48
    S1$164.63
    S2$160.30
    S3$157.45

    Advanced Oscillators

    TSI0.84
    Ultimate Osc58.2
    KST-9.27

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.06B$2.03B$2.19B$2.04B$2.02B$2.00B$2.04B$2.03B$2.12B$2.09B$2.07B$2.06B
    Cost of Revenue$1.67B$1.56B$1.69B$1.59B$1.46B$1.44B$1.44B$1.44B$1.49B$1.47B$1.45B$1.45B
    Gross Profit$388.53M$477.93M$500.89M$455.95M$561.60M$558.65M$599.37M$591.41M$626.56M$619.02M$620.52M$605.96M
    Operating Expenses$194.32M$304.19M$1.96B$197.05M$352.39M$339.09M$302.34M$305.98M$396.70M$333.52M$354.95M$341.65M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$194.32M$200.60M$179.70M$197.05M$205.01M$198.38M$151.44M$205.09M$194.46M$177.35M$195.56M$185.19M
    Operating Income$194.21M$173.73M$230.37M$258.90M$209.21M$219.56M$297.02M$285.43M$229.86M$285.50M$265.57M$264.31M
    Interest Income$3.15M$1.82M$1.49M$1.76M$2.05M$1.80M$3.01M$2.43M$1.24M$1.93M$1.72M$1.27M
    Interest Expense$48.79M$48.00M$40.11M$50.24M$50.15M$47.61M$51.43M$53.30M$60.84M$71.67M$81.03M$83.91M
    Income Before Tax$92.20M$127.56M$-120,502,000$38.10M$161.11M$173.75M$248.60M$234.56M$170.25M$215.76M$186.25M$181.68M
    Income Tax Expense$19.61M$22.81M$0$35.75M$-21,861,000$19.60M$-11,395,000$37.44M$23.34M$28.32M$-30,164,000$18.01M
    Net Income$72.58M$104.75M$-110,139,000$2.35M$182.97M$154.15M$260.00M$197.13M$146.91M$187.44M$216.42M$163.66M
    EBITDA$293.88M$277.33M$10.43M$186.84M$308.98M$317.32M$365.65M$380.90M$380.73M$436.61M$424.59M$411.62M
    EBIT$194.21M$187.00M$-80,396,000$88.34M$211.26M$221.36M$268.99M$287.87M$231.09M$287.43M$267.29M$265.58M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ICLR

    News

    ICON plc Stock 12‑Month Price Target Cut to $188.56, Implies 12% Upside

    ICON plc's average 12-month price target has been lowered to $188.56 from $189.81, according to 16 analysts, implying a 12% potential upside from the Oct. 14 closing price. Despite this reduction...

    TradingView•10/15/26•Neutral

    RBC Capital Keeps Their Buy Rating on Icon (ICLR)

    RBC Capital analyst Ryan Halsted has reiterated a Buy rating on Icon (ICLR) with a $185.00 price target, noting his success rate in the Healthcare sector. Despite the positive analyst consensus of a Moderate Buy...

    The Globe and Mail•10/13/26•Neutral

    RBC Capital Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $185

    RBC Capital has reiterated its Buy rating for Icon PLC (ICLR.US), a contract research organization. The firm also maintained its price target of $185 for the company's stock. This indicates RBC Capital's continued...

    Moomoo•10/12/26•Bullish

    ICON plc Stock 12‑Month Price Target Raised to $187.81, Implies 14% Upside

    Analysts have increased ICON plc's average 12-month price target from $186.25 to $187.81, suggesting a 14% potential upside from its Oct. 8 closing price. The consensus rating for the stock remains "Buy" among 20...

    TradingView•10/9/26•Bullish

    Results arrive after market close October 27 for ICON (ICLR), with an earnings call October 28.

    ICON plc (ICLR) announced it will release its third-quarter 2026 financial results after market close on October 27, 2026. A conference call and webcast to discuss these results are scheduled for October 28, 2026...

    Stock Titan•10/8/26•Neutral

    ICLR Valuation and Fair Value

    P/E
    16.8x
    Forward P/E
    14.8x
    EV/EBITDA
    20.8x
    P/FCF
    15.1x
    PEG
    0.5x
    P/B
    1.4x
    See GNG's fair value

    ICLR Profitability: Margins, ROIC and FCF

    Gross margin
    21.9%
    Operating margin
    9.4%
    Net margin
    0.3%
    ROIC
    2.0%
    ROE
    0.3%
    FCF margin
    10.8%
    FCF yield
    6.6%

    ICLR Competitors

    CompanyTicker
    Halozyme Therapeutics IncHALO
    Summit Therapeutics PLCSMMT
    Jazz Pharmaceuticals PLCJAZZ
    Baxter International IncBAX
    Neurocrine Biosciences IncNBIX
    BridgeBio Pharma IncBBIO
    Charles River LaboratoriesCRL
    Penumbra IncPEN

    Sector: Healthcare

    ICLR Analyst Ratings

    Consensus
    Hold
    Analysts
    18
    Strong Buy
    1
    Buy
    9
    Hold
    7
    Sell
    0
    Strong Sell
    1

    ICLR Bull Case vs Bear Case

    Bull case

    • ICLR beat EPS estimates in 75.0% of its last 8 reported quarters.

    ICLR Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    -2.9%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $2.65
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 3 down

    Frequently Asked Questions About ICLR

    Does ICLR pay dividends?

    ICON PLC (ICLR) does not currently pay a regular dividend.

    What is ICLR's P/E ratio?

    ICON PLC has a price-to-earnings (P/E) ratio of 16.84.

    What is ICLR's market cap?

    ICON PLC (ICLR) has a market capitalization of $13.04B with a current stock price of $175.13.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In